相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
Chiara Zanetta et al.
CLINICAL THERAPEUTICS (2014)
Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
Yusuke Echigoya et al.
NUCLEIC ACID THERAPEUTICS (2014)
Correlations Between Change Scores of Measures for Muscle Strength and Motor Function in Individuals with Spinal Muscular Atrophy Types 2 and 3
Hui-Yi Wang et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2013)
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2013)
Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy
Brent J. Barber et al.
JOURNAL OF PEDIATRICS (2013)
Mutation Types and Aging Differently Affect Revertant Fiber Expansion in Dystrophic Mdx and Mdx52 Mice
Yusuke Echigoya et al.
PLOS ONE (2013)
Antisense Therapy in Neurology
Joshua J. A. Lee et al.
JOURNAL OF PERSONALIZED MEDICINE (2013)
Splice Modulating Therapies for Human Disease
Pietro Spitali et al.
CELL (2012)
Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges
Virginia Arechavala-Gomeza et al.
CURRENT GENE THERAPY (2012)
UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene
Gaelle Blandin et al.
HUMAN MUTATION (2012)
被撤回的出版物: Modular Dispensability of Dysferlin C2 Domains Reveals Rational Design for Mini-dysferlin Molecules (Retracted article. See vol. 292, pg. 12543, 2017)
Bilal A. Azakir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3
Renske I. Wadman et al.
NEUROLOGY (2012)
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery
Yoshitsugu Aoki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Dysferlin and Animal Models for Dysferlinopathy
Kinji Kobayashi et al.
JOURNAL OF TOXICOLOGIC PATHOLOGY (2012)
Restoring Dystrophin Expression in Duchenne Muscular Dystrophy Muscle Progress in Exon Skipping and Stop Codon Read Through
Eric P. Hoffman et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Antisense drug discovery and development
Tsuyoshi Yamamoto et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
Mariko Taniguchi-Ikeda et al.
NATURE (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Targeting RNA to treat neuromuscular disease
Francesco Muntoni et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
Efficient Bypass of Mutations in Dysferlin Deficient Patient Cells by Antisense-Induced Exon Skipping
Nicolas Wein et al.
HUMAN MUTATION (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
Hans Heemskerk et al.
MOLECULAR THERAPY (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Antisense-mediated modulation of splicing Therapeutic implications for duchenne muscular dystrophy
Annemieke Aartsma-Rus
RNA BIOLOGY (2010)
A Naturally Occurring Human Minidysferlin Protein Repairs Sarcolemmal Lesions in a Mouse Model of Dysferlinopathy
Martin Krahn et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
A Renaissance for Antisense Oligonucleotide Drugs in Neurology
Toshifumi Yokota et al.
ARCHIVES OF NEUROLOGY (2009)
Characterization of Lipid Binding Specificities of Dysferlin C2 Domains Reveals Novel Interactions with Phosphoinositides
Christian Therrien et al.
BIOCHEMISTRY (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin
Chuanxi Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy
Jason H. Williams et al.
JOURNAL OF NEUROSCIENCE (2009)
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
R. Juliano et al.
MOLECULAR PHARMACEUTICS (2009)
Gene Knockdowns in Adult Animals: PPMOs and Vivo-Morpholinos
Jon D. Moulton et al.
MOLECULES (2009)
Limb-girdle muscular dystrophies
Michela Guglieri et al.
CURRENT OPINION IN NEUROLOGY (2008)
Asymptomatic sporadic dysferlinopathy presenting with elevation of serum creatine kinase. Typical distribution of muscle involvement shown by MRI but not by CT
Satomi Okahashi et al.
INTERNAL MEDICINE (2008)
Clinical and molecular overlap between myopathies and inherited connective tissue diseases
N. C. Voermans et al.
NEUROMUSCULAR DISORDERS (2008)
Partial functionality of a Mini-dysferlin molecule identified in a patient affected with moderately severe primary dysferlinopathy
M. Krahn et al.
NEUROMUSCULAR DISORDERS (2008)
Late onset in dysferlinopathy widens the clinical spectrum
L. Klinge et al.
NEUROMUSCULAR DISORDERS (2008)
Phenotypic study in 40 patients with dysferlin gene mutations -: High frequency of atypical phenotypes
Karine Nguyen et al.
ARCHIVES OF NEUROLOGY (2007)
Dysferlin in membrane trafficking and patch repair
Louise Glover et al.
TRAFFIC (2007)
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration
Toshifumi Yokota et al.
JOURNAL OF CELL SCIENCE (2006)
Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA)
Nadia Bendifallah et al.
BIOCONJUGATE CHEMISTRY (2006)
Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number
B Wirth et al.
HUMAN GENETICS (2006)
Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy
M Sinnreich et al.
NEUROLOGY (2006)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dysferlin and the plasma membrane repair in muscular dystrophy
D Bansal et al.
TRENDS IN CELL BIOLOGY (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Dysferlin interacts with Annexins A1 and A2 and mediates sarcolemmal wound-healing
NJ Lennon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Defective membrane repair in dysferlin-deficient muscular dystrophy
D Bansal et al.
NATURE (2003)
Prevalence of SMN1 deletion and duplication in carrier and normal populations:: implication for genetic counselling -: art. no. e39
V Cusin et al.
JOURNAL OF MEDICAL GENETICS (2003)
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies
DE Michele et al.
NATURE (2002)
Clinical heterogeneity in dysferlinopathy
H Ueyama et al.
INTERNAL MEDICINE (2002)
Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains
DB Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Function and genetics of dystrophin and dystrophin-related proteins in muscle
DJ Blake et al.
PHYSIOLOGICAL REVIEWS (2002)
Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy
YK Hayashi et al.
NEUROLOGY (2001)
Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation
E Vafiadaki et al.
NEUROREPORT (2001)
Structural organization, complete genomic sequences and mutational analyses of the Fukuyama-type congenital muscular dystrophy gene, fukutin
K Kobayashi et al.
FEBS LETTERS (2001)
Age and origin of the FCMD 3′-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population
R Colombo et al.
HUMAN GENETICS (2000)
The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin
IN Rybakova et al.
JOURNAL OF CELL BIOLOGY (2000)
The Fukuyama congenital muscular dystrophy story
T Toda et al.
NEUROMUSCULAR DISORDERS (2000)
分享论文
